Frédéric (Fred) Baribaud

A seasoned R&D leader with over 20 years of progressive responsibility across early translational research, clinical development, and digital innovation. Adept at transforming complex scientific data into compelling narratives, I have successfully built bridges between bench and boardroom by translating biomarkers, pipeline milestones, and collaborative innovation into investor-focused communications. My strong leadership, evidenced by managing multi-disciplinary teams and large-scale partnerships (both industrial and academic), uniquely positions me to drive Takeda’s R&D investor strategy, bolster investor confidence, and support strategic public disclosures. Core Competencies • R&D Pipeline Strategy & Communication: Expert in developing clinical and biomarker strategies and translating these into clear, investor-relevant messages. • Investor Relations & External Engagement: Experienced in preparing, presenting, and liaising with senior leaders, regulatory agencies, and external stakeholders to advocate pipeline progress. • Strategic Leadership: Over 20 years of cross-functional team management, project scoping, and execution—guiding teams through rigorous scientific and commercial environments. • Digital Health & CoDx Strategy: Proven ability to conceive and deploy CoDx/digital health strategies that enhance product differentiation and value communication. • Stakeholder Education & Training: Skilled in developing presentation materials and Q&A documents to brief internal stakeholders, ensuring informed, cohesive messaging. • Regulatory & Strategic Communications: Deep experience supporting regulatory submissions, advising on public disclosures, and designing protocols that meet complex compliance requirements.